Cargando…
Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
Autor principal: | Iwahori, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509023/ https://www.ncbi.nlm.nih.gov/pubmed/32767277 http://dx.doi.org/10.1007/s13300-020-00899-7 |
Ejemplares similares
-
Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”
por: Brooks, Anne B., et al.
Publicado: (2020) -
Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
por: Brooks, Anne, et al.
Publicado: (2019) -
Public Preferences regarding Data Linkage for Health Research: A Discrete Choice Experiment
por: Aitken, Mhairi, et al.
Publicado: (2018) -
Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment
por: Amaador, Karima, et al.
Publicado: (2022) -
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan
por: Bolt, Timothy, et al.
Publicado: (2018)